Answers are grounded in this paper and cite their sources.
This Viewpoint uses the example of power morcellator devices to discuss the wider scope of US Food and Drug Administration regulations and postmarketing surveillance necessary to ensure patient safety.
No takes yet. Share an insight, caveat, or question.
Redberg et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: